Glucosylceramide synthase activity and ceramide levels are modulated during cerebral ischemia after ischemic preconditioning

Journal of Cerebral Blood Flow and Metabolism

Volumn 24, Issue 6, 2004, Pages 623-627

  Takahashi, Kenzo ^a   Ginis, Irene ^a   Nishioka, Ryoji ^a   Klimanis, Dace ^a   Barone, Frank C ^b   White, Raymond F ^b   Chen, Yong ^a   Hallenbeck, John M ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Ceramide; Glucosylceramide synthase; Ischemic tolerance; Middle cerebral artery occlusion; Spontaneously hypertensive rats

Indexed keywords

CERAMIDE; CERAMIDE GLUCOSYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN LEVEL; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; HEMISPHERE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SPONTANEOUSLY HYPERTENSIVE RAT; STATISTICAL ANALYSIS;

EID: 2642521387     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WCB.0000119990.06999.A9     Document Type: Article

References (48)

1. Abe A, Radin NS, Shayman JA (1996) Induction of glucosylceramide synthase by synthase inhibitors and ceramide. Biochim Biophys Acta 1299:333-341
2. Ballou LR, Laulederkind SJ, Rosloniec EF, Raghow R (1996) Ceramide signalling and the immune response. Biochim Biophys Acta 1301:273-287
3. Barone FC, Price WJ, White RF, Willette RN, Feuerstein GZ (1992) Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci Biobehav Rev 16:219-233
4. Barone FC, White RF, Spera PA, Ellison J, Currie RW, Wang X, Feuerstein GZ (1998) Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29:1937-1950; discussion 1950-1931
5. Baxter GF (1997) Ischemic preconditioning of myocardium. Ann Med 29:345-352
6. Bleicher RJ, Cabot MC (2002) Glucosylceramide synthase and apoptosis. Biochim Biophys Acta 1585:172-178
7. Brugg B, Michel PP, Agid Y, Ruberg M (1996) Ceramide induces apoptosis in cultured mesencephalic neurons. J Neurochem 66:733-739
8. Chen J, Simon R (1997) Ischemic tolerance in the brain. Neurology 48:306-311
9. Chen Y, Ginis I, Hallenbeck JM (2001) The protective effect of ceramide in immature rat brain hypoxia-ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells. J Cereb Blood Flow Metab 21:34-40
10. Currie RW, Ellison JA, White RF, Feuerstein GZ, Wang X, Barone FC (2000) Benign focal ischemic preconditioning induces neuronal Hsp70 and prolonged astrogliosis with expression of Hsp27. Brain Res 863:169-181
11. Dirnagl U, Simon RP, Hallenbeck JM (2003) Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26:248-254
12. Furuya K, Ginis I, Takeda H, Chen Y, Hallenbeck JM (2001) Cell permeable exogenous ceramide reduces infarct size in spontaneously hypertensive rats supporting in vitro studies that have implicated ceramide in induction of tolerance to ischemia. J Cereb Blood Flow Metab 21:226-232
13. Furuya S, Mitoma J, Makino A, Hirabayashi Y (1998) Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells. J Neurochem 71:366-377
14. Ginis I, Schweizer U, Brenner M, Liu J, Azzam N, Spatz M, Hallenbeck JM (1999) TNF-alpha pretreatment prevents subsequent activation of cultured brain cells with TNF-alpha and hypoxia via ceramide. Am J Physiol 276:C1171-1193
15. Goodman Y, Mattson MP (1996) Ceramide protects hippocampal neurons against excitotoxic and oxidative insults, and amyloid beta-peptide toxicity. J Neurochem 66:869-872
16. Goswami R, Dawson G (2000) Does ceramide play a role in neural cell apoptosis? J Neurosci Res 60:141-149
17. Hannun YA (1996) Functions of ceramide in coordinating cellular responses to stress. Science 274:1855-1859
18. Hannun YA, Luberto C (2000) Ceramide in the eukaryotic stress response. Trends Cell Biol 10:73-80
19. Horton JW (1999) Tumor necrosis factor-alpha, sphingosine, ceramide: which is the appropriate marker of inflammation? Crit Care Med 27:2580-2581
20. Ichikawa S, Hirabayashi Y (1998) Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol 8:198-202
21. Inokuchi J, Kuroda Y, Kosaka S, Fujiwara M (1998) L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol stimulates ganglioside biosynthesis, neurite outgrowth and synapse formation in cultured cortical neurons, and ameliorates memory deficits in ischemic rats. Acta Biochim Pol 45:479-492
22. Ito A, Horigome K (1995) Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J Neurochem 65:463-466
23. Kirino T (2002) Ischemic tolerance. J Cereb Blood Flow Metab 22:1283-1296
24. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, Kamada T (1990) "Ischemic tolerance" phenomenon found in the brain. Brain Res 528:21-24
25. Komori H, Ichikawa S, Hirabayashi Y, Ito M (1999) Regulation of intracellular ceramide content in B16 melanoma cells. Biological implications of ceramide glycosylation. J Biol Chem 274:8981-8987
26. Komori H, Ichikawa S, Hirabayashi Y, Ito M (2000) Regulation of UDP-glucose:ceramide glucosyltransferase-1 by ceramide. FEBS Lett 475:247-250
27. Kubota M, Nakane M, Nakagomi T, Tamura A, Hisaki H, Ueta N, Inokuchi J, Hirayama A (2000) Sphingolipid biosynthesis by L-PDMP after rat MCA occlusion. Acta Neurochir Suppl 76:339-341
28. Kubota M, Narita K, Nakagomi T, Tamura A, Shimasaki H, Ueta N, Yoshida S (1996) Sphingomyelin changes in rat cerebral cortex during focal ischemia. Neurol Res 18:337-341
29. Liu J, Ginis I, Spatz M, Hallenbeck JM (2000) Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am J Physiol Cell Physiol 278:C144-C153
30. Liu YY, Han TY, Giuliano AE, Cabot MC (2001) Ceramide glycosylation potentiates cellular multidrug resistance. FASEB J 15:719-730
31. Liu YY, Han TY, Giuliano AE, Ichikawa S, Hirabayashi Y, Cabot MC (1999) Glycosylation of ceramide potentiates cellular resistance to tumor necrosis factor-alpha-induced apoptosis. Exp Cell Res 252:464-470
32. Luberto C, Kraveka JM, Hannun YA (2002) Ceramide regulation of apoptosis versus differentiation: a walk on a fine line. Lessons from neurobiology. Neurochem Res 27:609-617
33. Marks DL, Paul P, Kamisaka Y, Pagano RE (2000) Methods for studying glucosylceramide synthase. Methods Enzymol 311:50-59
34. McLaughlin B, Hartnett KA, Erhardt JA, Legos JJ, White RF, Barone FC, Aizenman E (2003) Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci U S A 100:715-720
35. Merrill AH Jr, Schmelz EM, Dillehay DL, Spiegel S, Shayman JA, Schroeder JJ, Riley RT, Voss KA, Wang E (1997) Sphingolipids-the enigmatic lipid class: biochemistry, physiology, and pathophysiology. Toxicol Appl Pharmacol 142:208-225
36. Mitoma J, Ito M, Furuya S, Hirabayashi Y (1998) Bipotential roles of ceramide in the growth of hippocampal neurons: promotion of cell survival and dendritic outgrowth in dose- and developmental stage-dependent manners. J Neurosci Res 51:712-722
37. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136
38. Nakane M, Kubota M, Nakagomi T, Tamura A, Hisaki H, Shimasaki H, Ueta N (2000) Lethal forebrain ischemia stimulates sphingo-myelin hydrolysis and ceramide generation in the gerbil hippocampus. Neurosci Lett 296:89-92
39. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM (1997) TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J Cereb Blood Flow Metab 17:483-490
40. Ohtsuki T, Ruetzler CA, Tasaki K, Hallenbeck JM (1996) Interleukin-1 mediates induction of tolerance to global ischemia in gerbil hippocampal CA1 neurons. J Cereb Blood Flow Metab 16:1137-1142
41. Pettus BJ, Chalfant CE, Hannun YA (2002) Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta 1585:114-125
42. Purcell JE, Lenhard SC, White RF, Schaeffer T, Barone FC, Chandra S (2003) Strain-dependent response to cerebral ischemic preconditioning: differences between spontaneously hypertensive and stroke prone spontaneously hypertensive rats. Neurosci Lett 339:151-155
43. Radin NS (1994) Glucosylceramide in the nervous system: a mini-review. Neurochem Res 19:533-540
44. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM (1997) Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res 748:267-270
45. Toman RE, Movsesyan V, Murthy SK, Milstien S, Spiegel S, Faden AI (2002) Ceramide-induced cell death in primary neuronal cultures: upregulation of ceramide levels during neuronal apoptosis. J Neurosci Res 68:323-330
46. Wang X, Yaish-Ohad S, Li X, Barone FC, Feuerstein GZ (1998) Use of suppression subtractive hybridization strategy for discovery of increased tissue inhibitor of matrix metalloproteinase-1 gene expression in brain ischemic tolerance. J Cereb Blood Flow Metab 18:1173-1177
47. Willaime S, Vanhoutte P, Caboche J, Lemaigre-Dubreuil Y, Mariani J, Brugg B (2001) Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur J Neurosci 13:2037-2046
48. Zimmermann C, Ginis I, Furuya K, Klimanis D, Ruetzler C, Spatz M, Hallenbeck JM (2001) Lipopolysaccharide-induced ischemic tolerance is associated with increased levels of ceramide in brain and in plasma. Brain Res 895:59-65